Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
SYNOPSYS INC CFO Shelagh Glaser acquired additional company stock through an employee program. On February 27, 2026, she obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, her direct holdings totaled 17,870 shares of common stock.
SYNOPSYS INC CFO Shelagh Glaser acquired additional company stock through an employee program. On February 27, 2026, she obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, her direct holdings totaled 17,870 shares of common stock.
Synopsys, Inc. director and president/CEO Ghazi Sassine reported an acquisition of company stock through an employee program. On February 27, 2026, he obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, his directly held common stock position increased to 74,156 shares.
Synopsys, Inc. director and president/CEO Ghazi Sassine reported an acquisition of company stock through an employee program. On February 27, 2026, he obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, his directly held common stock position increased to 74,156 shares.
SYNOPSYS INC Chief Accounting Officer Sudhindra Kankanwadi reported an acquisition of company stock through an employee plan. On 2026-02-27, Kankanwadi acquired 28.0000 shares of common stock at a price of $351.9000 per share under the Synopsys, Inc Employee Stock Purchase Plan. Following this transaction, direct holdings increased to 21714.0000 shares of Synopsys common stock.
SYNOPSYS INC Chief Accounting Officer Sudhindra Kankanwadi reported an acquisition of company stock through an employee plan. On 2026-02-27, Kankanwadi acquired 28.0000 shares of common stock at a price of $351.9000 per share under the Synopsys, Inc Employee Stock Purchase Plan. Following this transaction, direct holdings increased to 21714.0000 shares of Synopsys common stock.
Synopsys, Inc. has entered into a $250 million accelerated share repurchase (ASR) agreement with The Bank of Nova Scotia to buy back its common stock. Under the ASR terms, Synopsys will receive an initial delivery of approximately 513,000 shares, with any remaining shares to be settled on or before June 1, 2026. The final number of shares repurchased will depend on the average daily volume-weighted average price of Synopsys stock during the repurchase period, reduced by a discount.
Synopsys, Inc. has entered into a $250 million accelerated share repurchase (ASR) agreement with The Bank of Nova Scotia to buy back its common stock. Under the ASR terms, Synopsys will receive an initial delivery of approximately 513,000 shares, with any remaining shares to be settled on or before June 1, 2026. The final number of shares repurchased will depend on the average daily volume-weighted average price of Synopsys stock during the repurchase period, reduced by a discount.
Synopsys reported sharply higher revenue but much lower profit for the quarter ended January 31, 2026. Revenue rose 66% to $2.41 billion from $1.46 billion, driven mainly by the acquisition of Ansys, which contributed $885.6 million, and organic growth across most products and regions.
Despite the revenue surge, operating income fell to $203.0 million from $251.8 million, and net income attributed to Synopsys dropped to $65.0 million from $295.7 million. Diluted earnings per share declined to $0.34 from $1.89, reflecting heavy amortization of acquired intangibles, restructuring charges of $118.3 million, higher employee costs after the Ansys Merger, and much higher interest expense of $162.7 million tied to new long‑term debt.
The Design Automation segment nearly doubled revenue to $2.00 billion with a 47% adjusted operating margin, while Design IP revenue slipped to $407.0 million and its adjusted margin compressed to 16%. Cash flow from operations improved strongly to $856.8 million, even as Synopsys repaid $3.5 billion under its term loan and ended the quarter with $10.0 billion of Senior Notes outstanding and $2.13 billion in cash, cash equivalents and restricted cash.
Synopsys, Inc. reported very strong growth for the first quarter of fiscal 2026 and expanded its share repurchase capacity. Revenue rose to $2.409 billion from $1.455 billion a year earlier, reflecting major contributions from its Design Automation segment.
On a GAAP basis, net income was $65.0 million, or $0.34 per diluted share, down from $295.7 million, or $1.89 per share, largely due to higher amortization of acquired intangibles, stock-based compensation and restructuring charges. Non-GAAP net income increased to $718.5 million, or $3.77 per diluted share, from $473.2 million, or $3.03 per share.
For the second quarter of fiscal 2026, Synopsys targets revenue of $2.225–$2.275 billion and non-GAAP EPS of $3.11–$3.17. Full-year fiscal 2026 targets call for revenue of $9.56–$9.66 billion and non-GAAP EPS of $14.38–$14.46, based on an 18% non-GAAP tax rate. The board also replenished the stock repurchase program with authorization to buy up to $2.0 billion of common stock.
SYNOPSYS INC director Peter A. Shimer filed an initial ownership report on Form 3. This filing establishes his status as a reporting insider at the company and provides a baseline for any future trades. The form does not list any share purchases, sales, or other transactions.
Synopsys is asking stockholders to vote at its April 16, 2026 virtual annual meeting on five items, including electing ten directors, approving an amended and restated equity incentive plan, an advisory say-on-pay vote, ratifying KPMG as auditor, and a stockholder written-consent proposal the Board opposes.
The company highlights completion of its July 2025 acquisition of Ansys, which it says transformed Synopsys from an electronic design automation leader into a broader engineering solutions provider across industries such as automotive, aerospace, industrial and healthcare. Fiscal 2025 results included record revenue of $7.054 billion, approximately 15% year-over-year growth, GAAP operating margin of 13.0%, non-GAAP operating margin of 37.3%, operating cash flow of about $1.52 billion, free cash flow of about $1.35 billion, and backlog of $11.4 billion.
The proxy details board composition, committee responsibilities, risk oversight for areas such as cybersecurity and artificial intelligence, and executive and director compensation practices, emphasizing pay-for-performance, independent board leadership, and no increase to shares available under the equity plan while adding non-employee directors as eligible participants.
Synopsys, Inc. expanded its Board of Directors from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as a director and member of the Audit Committee, effective immediately. The Board determined he is an independent director, meets Nasdaq audit committee requirements, and qualifies as an “audit committee financial expert.”
Shimer will participate in Synopsys’ non-employee director compensation program, including an annual cash retainer of $140,000, an initial restricted stock award with a grant date fair market value of $350,000, and a prorated interim restricted stock award based on an annual $200,000 grant. Synopsys also disclosed that current directors Luis Borgen and Dr. Ajei Gopal will not be renominated and will remain on the Board through the 2026 annual meeting of stockholders.